Colchicine in COVID-19: an Old Drug, New Use

Journal article

Open access

Peer reviewed

Naomi Schlesinger, Bonnie L Firestein and Luigi Brunetti

Current pharmacology reports, Vol.6(4), pp.1-9

08/01/2020

Abstract

Anti-inflammatory

Antiviral

Colchicine

Colchicine-tubulin complex

COVID-19

Covid-19 (ATY Lau and A Kong, Section Editors)

SARS-CoV-2 infection

url

https://doi.org/10.1007/s40495-020-00225-6View

Version of Record (VoR) Open

6 Record Views

Title: Colchicine in COVID-19: an Old Drug, New Use
Creators: Naomi Schlesinger - New Brunswick, NJ 08903-0019 USA
Bonnie L Firestein - Piscataway, NJ 08854-8082 USA
Luigi Brunetti - New Brunswick, NJ USA
Publication Details: Current pharmacology reports, Vol.6(4), pp.1-9
Date published: 08/01/2020
Publisher: Springer International Publishing
Academic Unit: Pharmacy Practice and Administration (EMSOP); Medicine - Rheumatology and Connective Tissue Research (RWJMS)
Language: English
Resource Type: Journal article
Identifiers: 991031665715304646